Biogen Inc
XETRA:IDP
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
99.32
160.65
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
IDP
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 142.75 EUR,
Biogen Inc
is
hidden
.
Valuation History
Biogen Inc
IDP looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if IDP is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Biogen Inc.
Fundamental Analysis
IDP Profitability Score
Profitability Due Diligence
Score
IDP Solvency Score
Solvency Due Diligence
Score
Select up to 3 indicators:
Select up to 3 indicators:
Biogen’s ambitious bet on Alzheimer’s treatments, particularly its contentious drug Aduhelm, has experienced regulatory hurdles and sluggish uptake, creating a risk that significant R&D investments will fail to yield commensurate returns and weigh on margins.
If Biogen’s Alzheimer’s portfolio, including any follow-on therapies or next-generation products, achieves broader Medicare reimbursement and stronger clinical data, the company could capture a significant share of a vast, unmet market for neurodegenerative treatments.
Revenue & Expenses Breakdown
Biogen Inc
Balance Sheet Decomposition
Biogen Inc
Biogen Inc
Free Cash Flow Analysis
Biogen Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Biogen Inc
Wall St
Price Targets
IDP Price Targets Summary
Biogen Inc
According to Wall Street analysts, the average 1-year price target for
IDP
is 163.18 EUR
with a low forecast of 121.96 EUR and a high forecast of 230.53 EUR.
Dividends
Current shareholder yield for
BIIB is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IDP
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 142.75 EUR,
Biogen Inc
is
hidden
.